Texas 2023 - 88th Regular

Texas House Bill HB814

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to an acknowledgment on receipt of an opioid prescription drug.

Impact

If enacted, HB814 will result in significant changes to the process by which opioids are prescribed and dispensed. Pharmacists would be mandated to inform patients about the dangers of opioid addiction directly, ensuring that patients acknowledge this information through a signed form prior to receiving their medication. This requirement may lead to a greater emphasis on the responsibilities of pharmacists and may also enhance the roles that healthcare professionals play in educating patients about the medicines they are taking.

Summary

House Bill 814 aims to amend the Texas Health and Safety Code concerning the dispensing of opioid prescriptions. Specifically, the bill requires pharmacists to provide patients with an acknowledgment form that warns about the risks associated with opioid use, including addiction and overdose. This measure intends to enhance patient awareness and safety in the context of opioid prescriptions, which have been a growing concern within public health discussions in Texas.

Sentiment

The public and legislative sentiment around HB814 appears largely supportive, particularly among public health advocates and those concerned about the opioid crisis in Texas. Supporters argue that the bill is a necessary step towards mitigating the risk of addiction and increasing the accountability of pharmacists. However, some stakeholders may express concerns over increased burdens on pharmacists and implications for patient access to necessary medications, which could become points of contention during discussions.

Contention

Potential points of contention may arise regarding the balance between patient safety and access to medications. Critics might argue that the additional requirements on pharmacists could lead to delays in patient care or create administrative burdens that could detract from their focus on patient health. Additionally, stakeholders may debate the effectiveness of merely providing warnings as opposed to implementing more comprehensive measures to combat opioid use and addiction. Overall, while the bill is a proactive effort to address a pressing health issue, the implications for pharmacy practice and patient care will need thoughtful consideration.

Companion Bills

No companion bills found.

Previously Filed As

TX SB1986

Relating to warning labels for opioid prescription drugs.

TX SB17

Modifies provisions relating to opioid prescriptions

TX SB1024

Modifies provisions relating to opioid prescriptions

TX SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

TX HB388

AN ACT relating to prescription drugs.

TX HB389

AN ACT relating to prescription drugs.

TX HB2291

Opioids; containers; labeling; requirements; repeal

TX HB1791

Relating to the duties of a prescriber issuing an opioid prescription to treat acute pain.

TX A1821

Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

TX S4283

Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

Similar Bills

NJ A3359

Regulates provision of pharmaceutical services in nursing homes.

NJ S2990

Regulates provision of pharmaceutical services in long-term care facilities.

CA AB1366

Reimbursement for pharmacist services.

CA AB2571

Reimbursement for pharmacist services.

HI SB1245

Relating To Pharmacists.

TX HB3540

Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.

HI SB324

Relating To Pharmacists.

HI SB324

Relating To Pharmacists.